How a Healthcare B2B Company Cut Customer Acquisition Costs by 60%

Customer acquisition in healthcare B2B is expensive, slow, and complicated by procurement cycles that can stretch to 18 months or longer. Most digital marketing programmes in this space underperform not because the tactics are wrong, but because the funnel is built backwards: awareness spend without a clear path to commercial conversion, and content that educates without ever moving a prospect closer to a decision.

This case study walks through how a mid-sized healthcare technology company restructured its digital acquisition programme, reduced cost per qualified lead by 60% over 12 months, and built a pipeline that converted at a rate that justified further investment. The mechanics are transferable. The mindset shift is the harder part.

What Was the Starting Point?

The company in this case is a healthcare technology provider selling workflow management software to NHS trusts and private hospital groups. Annual contract values sat between £80,000 and £350,000. The sales team was experienced and the product had genuine reference customers. The marketing problem was not awareness. Decision-makers in target accounts knew the company existed. The problem was that marketing was generating leads that sales did not want to work.

I have seen this pattern more times than I can count across the agency years. Marketing reports on lead volume. Sales reports on pipeline. The two numbers look completely disconnected, and each team blames the other. When I joined an agency turnaround in the mid-2000s, one of the first things I did was sit in on the weekly sales meeting rather than the marketing review. The language was entirely different. Sales talked about specific accounts, specific objections, specific competitor moves. Marketing was talking about impressions and click-through rates. The gap between those two conversations was where the money was being lost.

In this healthcare case, the diagnostic was straightforward. The company was running Google Ads against broad healthcare IT keywords, generating inbound enquiries from a wide range of organisations, many of which were too small, in the wrong vertical, or at the wrong procurement stage to convert. Cost per lead looked acceptable on the dashboard. Cost per closed deal was quietly catastrophic.

How Was the Acquisition Strategy Rebuilt?

The rebuild started with a question that sounds obvious but rarely gets asked properly: who actually makes the buying decision, and what does their information-gathering process look like before they ever fill in a form?

In healthcare B2B, procurement decisions at this contract value typically involve a clinical lead, a digital transformation director or CIO, a procurement officer, and often a finance sign-off. Each of those roles has different information needs, different objections, and different content preferences. The existing marketing programme was producing content that sat somewhere in the middle, specific enough to confuse a procurement officer and not clinical enough to engage a clinical lead.

The first structural change was audience segmentation by role, not by organisation type. This sounds simple. Executing it across paid, organic, and email channels simultaneously is not. It required rebuilding the keyword strategy, rewriting the landing pages, and creating a content matrix that mapped assets to role and procurement stage. Semrush’s work on market penetration strategy is useful context here, particularly the distinction between capturing existing demand and building new demand. In healthcare B2B, most paid search is demand capture. The company was spending as if it were demand generation.

The second structural change was a tighter account list. Rather than running campaigns against any healthcare organisation that might conceivably buy, the team built a target account list of 280 organisations that met specific criteria: trust size, existing digital maturity, active procurement activity signals, and no existing contract with a direct competitor that was still inside its renewal window. This is the kind of commercial discipline that feels restrictive until you see what happens to conversion rates when you apply it.

What Did the Channel Mix Actually Look Like?

Before the restructure, budget allocation was roughly 70% paid search, 20% content and SEO, and 10% events and sponsorship. That mix reflected how the programme had grown organically, with paid search added when the team needed more leads quickly, and content bolted on because someone had read that it was important.

The restructured mix looked very different. Paid search budget was reduced and tightened to exact-match and phrase-match keywords with clear commercial intent. Broad match was removed almost entirely. The budget released from that tightening went into LinkedIn Sponsored Content targeting by job title and organisation, with creative mapped to the buying committee roles identified in the audience work. A smaller allocation went into a nurture programme built around the target account list, using a combination of email and retargeting.

The content programme was rebuilt around what I call procurement-stage mapping. Rather than producing content based on what the marketing team found interesting or what seemed to be generating traffic, every asset was assigned to a specific stage of the buying process and a specific role. A clinical lead in the early evaluation stage got different content from a procurement officer in the vendor shortlisting stage. This is not complicated in principle. It requires editorial discipline and a willingness to produce less content overall in exchange for content that does more work per piece.

If you are thinking through how this kind of restructure fits into a broader go-to-market approach, the Go-To-Market and Growth Strategy hub covers the strategic frameworks that sit behind decisions like channel mix and audience targeting in more depth.

Events were not cut. They were made more deliberate. Rather than sponsoring broad healthcare IT conferences for brand awareness, the team identified three specialist events where their target accounts were demonstrably present, and built pre-event, at-event, and post-event sequences around each one. The goal was not footfall on the stand. It was moving specific named accounts from awareness to active conversation.

What Happened to Attribution and Budget Decisions?

Attribution in long-cycle B2B is where most digital marketing programmes quietly fall apart. When a sales cycle runs 12 to 18 months and involves six to eight touchpoints across multiple channels and multiple stakeholders, last-click attribution does not just give you an incomplete picture. It actively misleads you.

The company’s original attribution model was effectively last-click. Paid search was getting credit for conversions that had been influenced by LinkedIn content, event attendance, and a piece of clinical evidence that a procurement officer had found through organic search three months earlier. Paid search looked like the hero. LinkedIn looked like an expensive experiment. The content programme looked like overhead.

I spent a period judging the Effie Awards, and one of the things that process reinforced for me is how rarely marketers can accurately account for what drove a commercial outcome. The best entries were honest about the limits of their measurement and made a coherent argument rather than claiming false precision. The companies that presented suspiciously clean attribution stories were usually the ones whose results fell apart under questioning.

The fix here was not a sophisticated multi-touch attribution model, though those have their place. It was a simpler change: a structured post-conversion interview with every new customer, asking them to describe their buying process in their own words. What triggered the initial search? What content did they find useful? When did they first feel confident enough to engage with sales? Who else was involved in the decision? This qualitative layer, combined with CRM data on touchpoints, gave the team a much more honest picture of what was actually driving conversion.

The budget reallocation that followed, reducing paid search and increasing LinkedIn and content investment, was the single biggest driver of the cost-per-acquisition improvement. Not better creative. Not a new technology platform. A more honest reading of where value was actually being created.

How Did the Content Programme Change?

The original content programme had produced a substantial library of blog posts, whitepapers, and case studies. The problem was not volume. It was that most of the content was written to demonstrate expertise rather than to move a specific type of prospect closer to a specific decision.

There is a version of content marketing that exists to make the marketing team feel productive. Long-form thought leadership pieces that get shared internally, praised at team meetings, and then quietly ignored by the people they were supposed to influence. I have commissioned that content. I have also watched it fail to generate a single qualified conversation.

The rebuilt content programme started with a much smaller number of assets, each one built around a specific question that a specific role asked at a specific stage of the buying process. A clinical lead evaluating workflow software in the NHS context wants to understand what implementation looks like in a trust environment, what the clinical governance implications are, and whether there is reference evidence from comparable organisations. That is a very different brief from a generic “why digital transformation matters in healthcare” piece.

The team also made a decision that felt uncomfortable at the time: they stopped gating most of their content. The assumption had been that gating drove lead capture. The reality, when they looked at the data, was that gating was suppressing consumption of the content that was doing the most work in the buying process. Prospects were not filling in forms to access whitepapers. They were bouncing. Removing gates from mid-funnel content increased consumption significantly and, counterintuitively, increased the quality of conversations that came through the ungated path.

For context on why go-to-market execution in sectors like this feels harder than it used to, Vidyard’s analysis of GTM complexity is worth reading. The short version: more stakeholders, longer cycles, and higher buyer scepticism mean that content has to do more work earlier in the process than it did five years ago.

What Were the Results After 12 Months?

The headline number was a 60% reduction in cost per qualified lead over 12 months. That figure is worth unpacking, because “qualified lead” was redefined as part of the process. The original definition was loose enough that almost any inbound enquiry counted. The new definition required the lead to come from a target account, involve a relevant buying role, and meet a minimum threshold on the sales qualification criteria. By that tighter definition, cost per lead went down even as the absolute number of leads also increased.

Pipeline conversion rate from qualified lead to closed deal improved from approximately 12% to 19% over the same period. That improvement was not entirely attributable to marketing. The sales team also changed how they handled early-stage conversations, using the role-specific content as part of their outreach rather than treating marketing assets as separate from the sales process. That integration, marketing and sales working from the same account list with the same content, is where the commercial leverage actually came from.

Total marketing spend over the 12-month period was broadly flat. The improvement came from reallocation, not from additional investment. This matters because it is the argument that justifies further investment in the following year. When you can demonstrate that smarter allocation of existing budget drove measurable commercial improvement, the conversation about growth investment becomes much easier to have.

The Forrester intelligent growth model, outlined in their summit highlights, frames this kind of efficiency gain as a prerequisite for sustainable growth investment. You earn the right to spend more by demonstrating that you spend well. That sequencing matters in B2B marketing, particularly in sectors like healthcare where budget scrutiny is high and marketing is often seen as a cost centre rather than a growth driver.

What Are the Transferable Lessons?

Healthcare B2B has specific characteristics: long procurement cycles, complex buying committees, regulatory sensitivity, and a buyer population that is sceptical of marketing in a way that consumer audiences are not. But the underlying lessons from this case apply more broadly to any B2B environment where deal values are high and sales cycles are long.

The first lesson is that lead volume is a vanity metric in high-value B2B. The number that matters is pipeline quality, and pipeline quality is determined by how precisely your acquisition programme targets the right accounts and the right roles within those accounts. Broad targeting feels efficient on a cost-per-click basis. It is expensive on a cost-per-closed-deal basis.

The second lesson is that attribution shapes budget decisions, and most attribution models in B2B are wrong in ways that systematically undervalue the channels doing the most work in the middle of the buying process. If you are making channel allocation decisions based on last-click data in a 12-month sales cycle, you are almost certainly over-investing in demand capture and under-investing in demand influence.

The third lesson is one I keep coming back to from the agency years. Marketing programmes that underperform are usually underperforming because of a strategic misalignment, not a tactical execution problem. Changing the creative, testing a new ad format, or switching platforms will not fix a programme that is targeting the wrong accounts with the wrong content at the wrong stage. The fix has to happen at the strategic level first.

For those building or rebuilding a B2B acquisition programme, Semrush’s overview of growth tools covers the technology layer that supports this kind of structured approach. The tools matter less than the strategy, but they do matter. BCG’s work on go-to-market strategy in complex sales environments is also useful for understanding how buying committee dynamics shape acquisition strategy across different sectors.

There is a version of digital marketing that is essentially theatre. It produces activity, generates reports, and keeps everyone busy without moving the commercial needle. The discipline in this case was refusing to accept that version, and being willing to make changes that felt uncomfortable, reducing paid search budget, removing content gates, tightening the account list, before the data fully proved the case. That willingness to act on incomplete information, guided by a clear commercial logic, is what separates marketing that drives growth from marketing that just documents activity. If you want to think through the broader strategic framework behind decisions like these, the Go-To-Market and Growth Strategy hub is a useful place to continue.

About the Author

Keith Lacy is a marketing strategist and former agency CEO with 20+ years of experience across agency leadership, performance marketing, and commercial strategy. He writes The Marketing Juice to cut through the noise and share what works.

Frequently Asked Questions